Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: J Pediatr. 2018 May 18;200:210–217.e1. doi: 10.1016/j.jpeds.2018.04.033

Table IV.

Pathogen Susceptibilities to Common Empiric Antimicrobial Regimens

Pathogen Ampicillin/Gentamicin N (%)123 3rd generation cephalosporin N (%)12
Group B streptococcus 162/162 (100) 162/162 (100)
E. coli 124/135 (91.9) 132/135 (97.8)
S. aureus4 35/37 (94.6) 39/43 (90.7)
Enterococcus spp.4 28/28 (100) 0/29 (0)
Other Gram Negative5 10/11 (90.9) 9/11 (81.8)
Klebsiella spp. 12/14 (85.7) 12/14 (85.7)V
Enterobacter spp. 10/11 (90.9) 6/11 (54.5)
Group A streptococcus 11/11 (100) 11/11 (100)
Other Gram Positive6 8/8 (100) 8/8 (100)
Salmonella spp. 6/6 (100) 6/6 (100)
S. pneumoniae 6/6 (100) 6/6 (100)
L. monocytogenes 4/4 (100) 0/4 (0)
Total 416/433 (96.1) 391/440 (88.9)
1

Denominators represent isolates with available susceptibility testing

2

Some cultures grew >1 organism

3

Gentamicin has poor cerebrospinal fluid penetration; pathogen considered ampicillin/gentamicin resistant if infant had bacterial meningitis and pathogen was ampicillin-resistant

4

6 isolates of S. aureus and 1 isolate of Enterococcus spp. had available susceptibility testing to third-generation cephalosporins but not to ampicillin/gentamicin

5

Includes Citrobacter spp. (3), Pseudomonas aeruginosa (2), Neisseria meningitidis (2), Moraxella spp. (2), Haemophilus influenzae non-typeable (2), Haemophilus parainfluenzae (1), Proteus spp. (1), Serratia spp. (1), Pasteurella spp. (1), Acinetobacter spp. (1)

6

Includes Streptococcus gallolyticus (4), Streptococcus bovis (4), Paenibacillus spp. (1)